Gabapentin

Product NDC
70518-2970
11-digit product format
705182970
Labeler code
70518
Product ID
70518-2970_4e5391f3-de17-7644-e063-6294a90ab56b
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Gabapentin
Dosage form
CAPSULE
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA204989
Marketing category
ANDA
Marketing start
2020-12-16
Substance
GABAPENTIN
Active strength
300 mg/1
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Gabapentin
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
GABAPENTIN300 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
Unii6CW7F3G59X
Rxcui310431

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
cdc2ae60-922e-452d-a42f-787fe4e2ed06Product name120250123
7059096a-4b9f-36c2-db50-bb5c723e6e9eProduct name220250114
fa3f0129-3502-889f-f424-3a37727959e7Product name920181206
77d89e4c-f57f-326d-d7aa-787f8eebbd2bProduct name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70518-2970-02024-03-09C16284748780-1d6a99b39-6756-a426-e053-dadaa90af4c2These highlights do not include all the information needed to use GABAPENTIN safely and effectively. See full prescribing information for GABAPENTIN. GABAPENTIN capsules, for oral use GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
70518-2970-02024-03-09C16284748780-1d6a99b39-6756-a426-e053-dadaa90af4c2These highlights do not include all the information needed to use GABAPENTIN safely and effectively. See full prescribing information for GABAPENTIN. GABAPENTIN capsules, for oral use GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
70518-2970-02024-01-30C16284748780-1d6a99b39-6756-a426-e053-dadaa90af4c2These highlights do not include all the information needed to use GABAPENTIN safely and effectively. See full prescribing information for GABAPENTIN. GABAPENTIN capsules, for oral use GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
70518-2970-02024-01-30C16284748780-1d6a99b39-6756-a426-e053-dadaa90af4c2These highlights do not include all the information needed to use GABAPENTIN safely and effectively. See full prescribing information for GABAPENTIN. GABAPENTIN capsules, for oral use GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
70518-2970-02022-02-10C16284748780-1d6a99b39-6756-a426-e053-dadaa90af4c2These highlights do not include all the information needed to use GABAPENTIN safely and effectively. See full prescribing information for GABAPENTIN. GABAPENTIN capsules, for oral use GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
70518-2970-02022-02-10C16284748780-1d6a99b39-6756-a426-e053-dadaa90af4c2These highlights do not include all the information needed to use GABAPENTIN safely and effectively. See full prescribing information for GABAPENTIN. GABAPENTIN capsules, for oral use GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
70518-2970-02022-01-28C16284748780-1d6a99b39-6756-a426-e053-dadaa90af4c2These highlights do not include all the information needed to use GABAPENTIN safely and effectively. See full prescribing information for GABAPENTIN. GABAPENTIN capsules, for oral use GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
70518-2970-02022-01-28C16284748780-1d6a99b39-6756-a426-e053-dadaa90af4c2These highlights do not include all the information needed to use GABAPENTIN safely and effectively. See full prescribing information for GABAPENTIN. GABAPENTIN capsules, for oral use GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
70518-2970-0Gabapentin30 in 1 BOTTLE, PLASTICCAPSULE3010
70518-2970-1Gabapentin90 in 1 BOTTLE, PLASTICCAPSULE9010

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
70518-2970-1EA - Each70518-2970461455e8-46e6-4bf6-8a22-3953d973193012026-01-08

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
310431gabapentin 300 MG Oral CapsulePSNe877a425-2b7f-4e43-a1f9-24019cbf968510
310431gabapentin 300 MG Oral CapsuleSCDe877a425-2b7f-4e43-a1f9-24019cbf968510

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70518-2970-07051829700030 CAPSULE in 1 BOTTLE, PLASTIC (70518-2970-0) 30 capsule2020-12-160000-00-00NoNoCurrent
70518-2970-17051829700190 CAPSULE in 1 BOTTLE, PLASTIC (70518-2970-1) 90 capsule2024-01-19NoNoCurrent